Saturday 17 October 2026
Export MEDP’s income statement to Excel — free account
Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024. In the quarter to June 2026, revenue grew 17.2%, EPS grew 36.4% and free cash flow fell 3.03%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for ten.
618.47
10.13
−1.61%
Follow MEDP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
9 | 9 | 8 | 8 |
+8 more TTM periods Free account |
| 162.15% | 77.25% | 70.23% | 73.71% | ||
| 27.09% | 22.87% | 22.13% | 22.57% | ||
ROIC |
0.00% | 0.00% | 0.00% | 3,822.71% | |
Return on Tangible Assets |
(215.54%) | (663.29%) | (202.23%) | (104.74%) | |
Average Days of Receivables |
57.96 | 53.77 | 58.00 | 57.73 | |
Free Cash Flow per Share |
25.08 | 25.00 | 23.64 | 24.05 | |
Free Cash Flow |
706.69 | 711.00 | 681.87 | 676.77 | |
Capital Expenditures |
(45.97) | (28.18) | (31.36) | (34.46) | |
| Other line items | |||||
Cash ROIC |
75.46% | 56.83% | 71.32% | 116.89% | |
Accounts Receivable Turnover |
6.79 | 7.73 | 7.24 | 6.89 | |
Accounts Payable Turnover |
19.04 | 15.72 | 24.13 | 27.22 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
17.80 | 16.70 | 14.03 | 13.49 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.18) | (0.19) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.79% | 7.00% | 7.81% | 8.40% | |
Share Based Compensation of Revenue |
0.76% | 0.85% | 1.37% | 1.49% | |
Interest Coverage |
(38.03) | (49.23) | (41.86) | (29.93) | |
Operating CF/Net income |
1.53 | 1.61 | 1.58 | 1.64 | |
Depreciation/Fixed assets |
0.18 | 0.21 | 0.21 | 0.21 | |
Capex/Depreciation |
(1.65) | (1.00) | (1.11) | (1.21) | |
Revenue per Share |
98.75 | 94.16 | 87.72 | 83.82 | |
Operating CF per Share |
26.71 | 25.99 | 24.73 | 25.28 | |
Capex per Share |
(1.63) | (0.99) | (1.09) | (1.22) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 |
Columns are period end dates